A new study by Harvard University economist Rebecca Diamond suggests that women who begin taking GLP-1 weight-loss medications may experience improved employment prospects alongside the health benefits of the drugs.
Using data from the University of Southern California's Understanding America Study, Diamond found that previously unemployed women who started GLP-1 treatment were about 27% more likely to secure employment after approximately 18 months compared with a similar group that had expressed interest in the medications but had not yet begun treatment.
However, participants did not report significant changes in overall life satisfaction, and the available data were insufficient to determine whether employment gains translated into higher earnings.
Diamond cautioned that the study identifies an association rather than proving a direct cause-and-effect relationship.
The findings contribute to growing research examining the wider social impact of GLP-1 weight-loss therapies.
Related Tweet:
As more people find success on weight-loss medications, they are likely to narrow the employment gap between overweight and average-weight job seekers. https://t.co/stNeSWBqKo
— Bloomberg (@business) June 30, 2026
Also Read:
TIPP Staff
